MISHC Data Reported at TCT.25 Sheds Light on Stroke Occurrence and Patient Quality of Life After TAVR
It is reported that 1 – 4% of patients experience stroke after TAVR, with most occurrences recognized within the first 48 hours.
While stroke is associated with worse clinical outcomes, its impact on patient-reported quality of life is unclear.
A team reviewed demographic, clinical, and procedural information from 18,633 TAVR patients across Michigan collected between January 2016 and January 2024. Patient quality of life was measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) at baseline, 30-days, and 1-year post-TAVR.
Dr. P. Michael Grossman presented the findings in Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience during TCT.25, held October 25 – 28 in San Francisco.
The study revealed that 1.78% of TAVR patients experienced a stroke before discharge, and stroke is associated with increased risk of death, transfusion, new dialysis, length of hospital stay, and not being discharged home.
Patients who had a stroke reported a much lower quality of life at 30 days post-procedure, and one-year scores also trended lower.
Efforts to avoid stroke after TAVR – including continued research – are needed for improved quality of life and patient outcomes.
Co-authors are Rita Corum, MD; Raed Alnajjar, MD; Stanley Chetcuti, MD; and Himanshu Patel, MD.
You can read more about this study at jacc.org.